Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.51 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 5/20 | 0.36 |
| ▸ | KMT5A | Q9NQR1 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL851109 | 0.89 | ZDHHC20 (0.54) | ZDHHC20ZDHHC2GAAALDH1A1TSHR | |
| SCHEMBL307977 | 0.85 | ZDHHC20 (0.51) | ZDHHC20ZDHHC2GAAALDH1A1TSHR | |
| SCHEMBL515065 | 0.84 | ZDHHC20 (0.50) | ZDHHC20ZDHHC2GAAALDH1A1TSHR | |
| SCHEMBL9396161 | 0.83 | ZDHHC20 (0.49) | ZDHHC20ZDHHC2GAAALDH1A1TSHR | |
| SCHEMBL4349259 | 0.82 | ZDHHC20 (0.55) | ZDHHC20ZDHHC2GAAALDH1A1TSHR | |
| SCHEMBL18176149 | 0.79 | ZDHHC20 (0.62) | ZDHHC20ZDHHC2GAAALDH1A1TSHR | |
| SCHEMBL31384454 | 0.79 | ZDHHC20 (0.49) | ZDHHC20ZDHHC2GAAALDH1A1TSHR | |
| SCHEMBL9396060 | 0.79 | ZDHHC20 (0.45) | ZDHHC20ZDHHC2GAAALDH1A1TSHR | |
| SCHEMBL9396182 | 0.79 | ZDHHC20 (0.45) | ZDHHC20ZDHHC2GAAALDH1A1TSHR | |
| SCHEMBL1659840 | 0.79 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2GAAALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432808-B1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | NOVARTIS AG (CH) | 2015-10-21 | — | — | EP | claimed |
| US-9097839-B2 | Method for making silicone hydrogel contact lenses | NOVARTIS AG (CH) | 2015-08-04 | — | — | US | claimed |
| US-8383744-B2 | Actinically-crosslinkable siloxane-containing copolymers | NOVARTIS AG (CH) | 2013-02-26 | — | — | US | claimed |
| US-20120172478-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2012-07-05 | — | — | US | claimed |
| US-8163206-B2 | Method for making silicone hydrogel contact lenses | NOVARTIS AG (CH) | 2012-04-24 | — | — | US | claimed |
| EP-2432808-A1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | Novartis AG (CH) | 2012-03-28 | — | — | EP | claimed |
| EP-2374031-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | Novartis AG (CH) | 2011-10-12 | — | — | EP | claimed |
| WO-2010133680-A1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | NOVARTIS AG (CH) | 2010-11-25 | — | — | WO | claimed |
| US-20100296049-A1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | ALCON INC. (CH) | 2010-11-25 | — | — | US | claimed |
| US-20100258961-A1 | Method for making silicone hydrogel contact lenses | ALCON INC. (CH) | 2010-10-14 | — | — | US | claimed |
| WO-2010071691-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | NOVARTIS AG (CH) | 2010-06-24 | — | — | WO | claimed |
| EP-3486711-A1 | LENS-FORMING MATERIALS COMPRISING PREPOLYMERS SUITABLE FOR MAKING ULTRA-VIOLET ABSORBING CONTACT LENSES | Novartis AG (CH) | 2019-05-22 | — | — | EP | disclosed |
| US-9097839-B2 | Method for making silicone hydrogel contact lenses | NOVARTIS AG (CH) | 2015-08-04 | — | — | US | disclosed |
| US-9066981-B2 | Actinically-crosslinkable siloxane-containing copolymers | NOVARTIS AG (CH) | 2015-06-30 | — | — | US | disclosed |
| US-20140100291-A1 | Actinically-Crosslinkable Siloxane-Containing Copolymers | NOVARTIS AG (CH) | 2014-04-10 | — | — | US | disclosed |
| WO-2011034801-A1 | PREPOLYMERS SUITABLE FOR MAKING ULTRA-VIOLET ABSORBING CONTACT LENSES | NOVARTIS AG (CH) | 2011-03-24 | — | — | WO | disclosed |
| US-20110063567-A1 | PREPOLYMERS SUITABLE FOR MAKING ULTRA-VIOLET ABSORBING CONTACT LENSES | ALCON INC. (CH) | 2011-03-17 | — | — | US | disclosed |
| US-20100298446-A1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | ALCON INC. (CH) | 2010-11-25 | — | — | US | disclosed |
| US-20100258961-A1 | Method for making silicone hydrogel contact lenses | ALCON INC. (CH) | 2010-10-14 | — | — | US | disclosed |
| WO-2010071691-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | NOVARTIS AG (CH) | 2010-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100296049-A1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | VCL, MACF1, CFL1 | ZDHHC20 1195/4885ZDHHC2 611/4885GAA 3338/4885 |
| US-20100298446-A1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | ATRIP, ATR, MACF1 | ZDHHC20 4124/4885ZDHHC2 3437/4885GAA 4052/4885 |
| US-20140100291-A1 | Actinically-Crosslinkable Siloxane-Containing Copolymers | ATRIP, ATR, MACF1 | ZDHHC20 4124/4885ZDHHC2 3437/4885GAA 4052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.